Precision Biosciences (DTIL) Gains from Sales and Divestitures (2018 - 2026)
Precision Biosciences (DTIL) posted Gains from Sales and Divestitures of $1,000 for fiscal Q2 2026 (quarter ended Jun 30, 2026), compared with -$25,000 a year earlier and down 75.0% from the prior quarter.
Powered by 
Analysis
Precision Biosciences (DTIL) Gains from Sales and Divestitures (2018 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Gains from Sales and Divestitures at Precision Biosciences was $894,000; for FY2025 (ended Dec 31, 2025), it was $855,000.
- In prior fiscal years, Precision Biosciences' Gains from Sales and Divestitures was -$436,000 in FY2024, $8.45 million in FY2023, -$106,000 in FY2022 and -$26,000 in FY2021.
- Quarterly Gains from Sales and Divestitures has run from a low of -$189,000 in fiscal Q2 2024 to a high of $8.38 million in fiscal Q3 2023 over five years.
- According to Business Quant data, Gains from Sales and Divestitures for the three prior fiscal quarters was $4,000 (Q1 2026), $886,000 (Q4 2025) and $3,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Precision Biosciences | 166.80 Mn | -182.39 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1,000.00 |
| Mar 31, 2026 | 4,000.00 |
| Dec 31, 2025 | 886,000.00 |
| Sep 30, 2025 | 3,000.00 |
| Jun 30, 2025 | -25,000.00 |
| Mar 31, 2025 | -9,000.00 |
| Dec 31, 2024 | -182,000.00 |
| Jun 30, 2024 | -189,000.00 |
| Mar 31, 2024 | -65,000.00 |
| Sep 30, 2023 | 8.38 Mn |
| Jun 30, 2023 | 72,000.00 |
| Mar 31, 2023 | -7,000.00 |
| Dec 31, 2022 | -48,000.00 |
| Jun 30, 2022 | -47,000.00 |
| Mar 31, 2022 | -11,000.00 |
| Dec 31, 2021 | -3,000.00 |
| Mar 31, 2021 | -23,000.00 |
| Dec 31, 2020 | -57,000.00 |
| Jun 30, 2020 | 22,000.00 |
| Dec 31, 2018 | -6,000.00 |
API Access
Precision Biosciences Gains from Sales and Divestitures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=DTIL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gains-from-sales-and-divestitures", "ticker": "DTIL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=DTIL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();